Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Advaxis reports update on phase II study of ADXS-HPV

Jan. 29, 2015

FDA clears IND for phase I study of ADXS-HER2

Jan. 23, 2015

Phase I/II results of isactuzumab govitecan in gastrointestinal cancer patients

Jan. 22, 2015

BioInvent's BI-1206 to enter collaborative phase I/II trial

Jan. 21, 2015

Safety and dosing data presented for a novel gastric cancer vaccine

Jan. 19, 2015

OncoMed enrolls first biomarker-selected patient in anti-Notch 1 expansion trial

Jan. 16, 2015

Promising results presented for chimeric antigen receptors in B-cell cancer treatment

Jan. 15, 2015

Precision Biologics discloses interim survival data for NPC-1C in metastatic colorectal cancer

Jan. 15, 2015

EMA grants positive opinion for orphan drug status for enadenotucirev

Jan. 14, 2015

Asana BioSciences researchers prepare immunofusion molecules for cancer

Jan. 14, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...